Hamartoma diagnostic study of choice

Revision as of 06:55, 22 January 2019 by Shyam Patel (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Hamartoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Hamartoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Hamartoma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Hamartoma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Hamartoma diagnostic study of choice

CDC on Hamartoma diagnostic study of choice

Hamartoma diagnostic study of choice in the news

Blogs on Hamartoma diagnostic study of choice

Directions to Hospitals Treating Hamartoma

Risk calculators and risk factors for Hamartoma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Shyam Patel [2]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [3]

Overview

The diagnostic study of choice of hamartomas is tissue biopsy.

Diagnostic study of choice

The diagnostic study of choice of hamartomas is tissue biopsy. However, imaging such as CT or MRI can also help to assess for hamartoma.

References


Template:WikiDoc Sources